Results 321 to 330 of about 1,264,680 (377)

Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study. [PDF]

Acta Ophthalmol
Abu Ishkheidem I, Breimer M, Kamal S, Zetterberg M, Al-Hawasi A, Grönlund MA.   +5 more
europepmc   +1 more source

The impact of the COVID‐19 pandemic on the diagnosis and management of pre‐eclampsia: Identifying healthcare delays

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare the prevalence of pre‐eclampsia with and without severe features, and maternal and perinatal outcomes before and during the COVID‐19 pandemic. Methods Cross‐sectional study based on medical chart review of pregnant women admitted to a referral maternity hospital for childbirth between September 2019 to February 2020 ...
Juliana da‐Costa‐Santos, Vitor V. L. Reis, Rodolfo R. Japecanga, Mariana Seabra, Maykon Anderson Carvalho, Ana Julia Ganzeli Oliveira, Laura Cintra Vinchi, Arthur B. P. Righi, Jussara Mayrink, José Paulo S. Guida, Renato T. Souza, José G. Cecatti, Maria Laura Costa   +12 more
wiley   +1 more source

Ocular hypertension after silicone oil filling surgery for high myopia: a case-control study. [PDF]

BMC Surg
Lin X, Feng S, Chen C, Xiong Y, Li N, Tong L.   +5 more
europepmc   +1 more source

A Pilot Study on Predicting Ocular Hypertension in Chinese Patients Undergoing Femtosecond Laser-Assisted Penetrating Keratoplasty. [PDF]

Int J Med Sci
Cao X, Huang J, Liu Y, Gong Y, Wang D, Wang M, Li Z, Ma J, Wang L.   +8 more
europepmc   +1 more source

Regulation of disease-associated microglia in the optic nerve by lipoxin B₄ and ocular hypertension. [PDF]

Mol Neurodegener
Maurya S, Lin M, Karnam S, Singh T, Kumar M, Ward E, Sivak J, Flanagan JG, Gronert K.   +8 more
europepmc   +1 more source

Risk for Ocular Hypertension With Intravitreal Dexamethasone Implants in Black and White Patients With Diabetic Macular Edema. [PDF]

J Vitreoretin Dis
Leung EH, Alsoudi AF, Skrehot HC, Burkhead D, Adcock B, Behl I, Chin Yee D.   +6 more
europepmc   +1 more source

Effectiveness and Safety of Switching to Fixed-Dose, Preservative-Free Tafluprost/Timolol in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: A Real-World Study in Taiwan. [PDF]

Cureus
Su WW, Lee YS.
europepmc   +1 more source

Tear micro RNA expression signature in primary open-angle glaucoma versus ocular hypertension.

, 2019
M.D. Pinazo-Durán, J. Raga-Cervera, Silvia Maria Sanz-Gonzalez, José Javier García‐Medina, María Isabel López Gálvez, Vicente Zanón‐Moreno   +5 more
openalex   +1 more source

Responsiveness to Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension.

JAMA Ophthalmol
Yang Y, Xu K, Chen Z, Zhang Y, Ye Q, Ping YT, Fan Y, Liu P, Nathwani N, Jiang Y, Gazzard G, Yu M, LiGHT China Trial Study Group.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Anti‐PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model

Journal of Pineal Research, 2022
Acute ocular hypertension (AOH) is the most important characteristic of acute glaucoma, which can lead to retinal ganglion cell (RGC) death and permanent vision loss. So far, approved effective therapy is still lacking in acute glaucoma.
Dan Ye, Yue Xu, Yuxun Shi, Matthew Fan, Peng Lu, Xue Bai, Yanlin Feng, Chenyang Hu, Kaixuan Cui, Xiaoyu Tang, Jing Liao, Wei Huang, Fan Xu, Xiaoling Liang, Jingjing Huang   +14 more
semanticscholar   +1 more source